Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

By L. Bonanni, Astrid Thomas, M. Onofrj. Neurology, 2005

2,373 citations recorded by the source corpus.

Subfields: Neurology, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/eb4d79478108587f342aa7da3948db3e27f5b702

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

In Physiology

In Psychiatry and Mental health

Citations in the corpus

Introduction to Revised Criteria for the Diagnosis of Alzheimer’s Disease: National Institute on Aging and the Alzheimer Association Workgroups (2011, background): “Thus, the set of recommendations presented in this article only refer to other disorders because they relate to differential diagnosis of AD.”
The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease (2011, background): “AD dementia refers to the clinical syndrome that arises as a consequence of the AD pathophysiological process.”
Classifying neurocognitive disorders: the DSM-5 approach (2014, background): “The development of the DSM‑5 criteria for the various subtypes involved extensive discussions with experts from diverse fields to harmonize the DSM criteria with cri‑ teria developed by other expert groups, such as the NIA– AA, 20,27 the frontotemporal dementia expert group, 28,29 the consortium on ”
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. (2009, methodology): “The selection of regions was based on the currently used staging and grading systems for Lewy body disorders (Braak et al., 2003; McKeith et al., 2005).”
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. (2018, methodology): “Diagnostic criteria for DLB were first devised in 1996 and revised in 2005 by the DLB Consortium (McKeith et al. 2005).”
Mitochondrial Dysfunction in Parkinson's Disease (2011, methodology): “Abbreviations AAT: Amino acid transporter ATP: Adenosine triphosphate CNS: Central nervous system DA: Dopaminergic DAT: Dopamine transporter DLB: Dementia with Lewy bodies e−: Electron GSH: Glutathione H+: Proton H2O2: Hydrogen peroxide ILBD: Incidental Lewy body disease LB: Lewy body LN: Lewy Neuri”
Parkinson's disease: genetics and pathogenesis. (2011, background): “DLB is characterized clinically by parkinsonism and early development of dementia, often accompanied by prominent visual hallucinations and fluctuations in arousal (24).”
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders (2010, positive): “The Unified Staging System is a modification of the scheme first devised by the Dementia with Lewy Bodies Consortium [8, 58, 59].”
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration (2007, methodology): “the brain of a patient with FTLD, other neurodegenerative diseases may be identiWed, most commonly AD [18], DLB [52], and, rarely, prion disease [33] and hereditary diVuse leukoencephalopathy with axonal spheroids [76].”
Unified Staging System for Lewy Body Disorders: Correlation with Nigrostriatal Degeneration, Cognitive Impairment and Motor Dysfunction (2009, methodology): “disorders were staged according to Braak [16] as well as the Dementia with Lewy Bodies Consortium [ 67 ].”